The head of the pharmaceutical giant warns that Europe's decline in manufacturing innovative medicines is likely to accelerate as a result of the policies pursued by Donald Trump. According to Soriot, all new factories producing the medicines of tomorrow will be built across the Atlantic.

https://archive.is/GmyLR

Soriot points out that Europe now faces a double threat. On one hand, major pharmaceutical companies are investing heavily in the United States to avoid their products being heavily taxed by the Trump administration. On the other, China is already a leader in generics and has become a formidable competitor in innovative medicines.